Company profile: PMG Research
1.1 - Company Overview
Company description
- Provider of integrated clinical research through a network of facilities operating from 12 U.S. metropolitan areas, conducting trials since 1979. Offerings include Accellacare studies on medical conditions such as migraines, post-surgical neuropathy, and COVID-19 vaccines; The Patient Voice feedback program; Lunch and Learn; and Tell a Friend referral program.
Products and services
- Accellacare Clinical Research: Operates a multi-site network of clinical research sites conducting studies on migraines, post-surgical neuropathy, and COVID-19 vaccines, supporting organized trial activity across dedicated research facilities
- Tell a Friend: Delivers an incentive-based referral program where participants recommend others for clinical trials and receive a gift card if the referral qualifies, increasing recruitment through peer outreach
- The Patient Voice: Offers a feedback-driven patient engagement program allowing patients to provide input on clinical research initiatives, systematically collecting participant perspectives on study topics and experiences
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PMG Research
Pharm-Olam
HQ: United States
Website
- Description: Provider of comprehensive clinical research services as a multi-national contract research organization serving pharmaceutical, biotechnology, and medical device industries, with a global network including Central Eastern Europe, Latin America, and India to enable patient recruitment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharm-Olam company profile →
Phaxiam Therapeutics
HQ: France
Website
- Description: Provider of bacteriophage-based therapies to combat antimicrobial-resistant bacterial infections, offering phage treatments, GMP individualized phage therapies (IPT), standardized phage therapies medicinal products (PTMP), a phage portfolio targeting Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, an in vitro Phagogram test for phage susceptibility, and PhagoDAIR clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phaxiam Therapeutics company profile →
Quay Pharma
HQ: Australia
Website
- Description: Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quay Pharma company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
ProSciento
HQ: United States
Website
- Description: Provider of clinical research and development services, leveraging broad scientific expertise, direct patient access, advanced methodologies, and integrated operations to advance science and achieve quality results through client and partner connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProSciento company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PMG Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PMG Research
2.2 - Growth funds investing in similar companies to PMG Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PMG Research
4.2 - Public trading comparable groups for PMG Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →